Smoking and papillomavirus DNA in patients with p16-positive N3 oropharyngeal squamous cell carcinoma

被引：3
作者：
Gorphe, Philippe [1 ]
Chekkoury Idrissi, Younes [1 ]
Tao, Yungan [2 ]
Moya-Plana, Antoine [1 ]
Casiraghi, Odile [3 ]
Janot, Francois [1 ]
Blanchard, Pierre [2 ]
Mirghani, Haitham [1 ]
Temam, Stephane [1 ]
机构：
[1] Univ Paris Saclay, Inst Gustave Roussy, Dept Head & Neck Oncol, Villejuif, France
[2] Univ Paris Saclay, Inst Gustave Roussy, Dept Radiotherapy, Villejuif, France
[3] Univ Paris Saclay, Inst Gustave Roussy, Dept Pathol, Villejuif, France
来源：
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK | 2019年 / 41卷 / 04期
关键词：
human papillomavirus; N3; oropharyngeal neoplasms; p16; immunohistochemistry; smoking history; POSITIVE HEAD; CANCER; OUTCOMES; CHEMORADIOTHERAPY; RISK; RADIOTHERAPY; INTEGRATION; PROGNOSIS; RADIATION; SURVIVAL;
D O I：
10.1002/hed.25523
中图分类号：
R76 [耳鼻咽喉科学];
学科分类号：
100213 ;
摘要：
Background We investigated the survival of patients with a p16-positive N3 oropharyngeal squamous cell carcinoma (OPSCC) and the prognostic significance of patient, tumor, and treatment characteristics. Methods We retrospectively reviewed the data of patients treated at our Cancer Center for a p16-positive N3 OPSCC between 2003 and 2016. End points were overall survival (OS) and progression-free survival (PFS). Results A total of 29 patients were included. The 5-year OS and PFS were 67.5% and 59.1%, respectively. Smoking history above 10 pack-years and the absence of human papillomavirus DNA were associated with worse OS (P = .02 and P = .03, respectively) and PFS (P = .02 and P = .02, respectively). Induction chemotherapy or radical neck dissection were not associated with different treatment outcomes. Conclusion Patients with an N3 p16-positive oropharyngeal cancer in our series had a 5-year OS rate of 67.5%. Smoking history and viral DNA were prognostic factors associated with survival.
引用
收藏
页码：1039 / 1045
页数：7
相关论文
共 50 条
  • [21] The Prognostic Significance of the Biomarker p16 in Oropharyngeal Squamous Cell Carcinoma
    Oguejiofor, K. K.
    Hall, J. S.
    Mani, N.
    Douglas, C.
    Slevin, N. J.
    Homer, J.
    Hall, G.
    West, C. M. L.
    [J]. CLINICAL ONCOLOGY, 2013, 25 (11) : 630 - 638
  • [22] Multiple Mutations-A Genetic Marker for Extracapsular Spread in Human Papillomavirus/p16-Positive Oropharyngeal Carcinoma
    Graessle, Raphaela
    Piwonski, Iris
    Husemann, Cora
    Kleo, Karsten
    Sabtan, Deema
    Franzen, Achim
    Olze, Heidi
    Erben, Ulrike
    Hummel, Michael
    Coordes, Annekatrin
    [J]. LARYNGOSCOPE INVESTIGATIVE OTOLARYNGOLOGY, 2025, 10 (01):
  • [23] Differences in clinical and imaging characteristics between p16-positive non-smokers and p16-positive smokers or p16-negative patients in oropharyngeal carcinoma
    Trinh, Jean-Michel
    Thomas, Jacques
    Salleron, Julia
    Henrot, Philippe
    [J]. SCIENTIFIC REPORTS, 2021, 11 (01)
  • [24] Association of pretreatment body mass index and survival in human papillomavirus positive oropharyngeal squamous cell carcinoma
    Albergotti, William G.
    Davis, Kara S.
    Abberbock, Shira
    Bauman, Julie E.
    Ohr, James
    Clump, David A.
    Heron, Dwight E.
    Duvvuri, Umamaheswar
    Kim, Seungwon
    Johnson, Jonas T.
    Ferris, Robert L.
    [J]. ORAL ONCOLOGY, 2016, 60 : 55 - 60
  • [25] Detection of circulating HPV16 DNA as a biomarker in the blood of patients with human papillomavirus-positive oropharyngeal squamous cell carcinoma
    Mazurek, Agnieszka M.
    Rutkowski, Tomasz
    Snietura, Miroslaw
    Piglowski, Wojciech
    Suwinski, Rafal
    Skladowski, Krzysztof
    [J]. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2019, 41 (03): : 632 - 641
  • [26] Impact of p16, p53, smoking, and alcohol on survival in patients with oropharyngeal squamous cell carcinoma treated with primary intensity-modulated chemoradiation
    Broglie, Martina A.
    Soltermann, Alex
    Rohrbach, David
    Haile, Sarah R.
    Pawlita, Michael
    Studer, Gabriela
    Huber, Gerard F.
    Moch, Holger
    Stoeckli, Sandro J.
    [J]. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2013, 35 (12): : 1698 - 1706
  • [27] Improved survival of Japanese patients with human papillomavirus-positive oropharyngeal squamous cell carcinoma
    Mizumachi, Takatsugu
    Kano, Satoshi
    Sakashita, Tomohiro
    Hatakeyama, Hiromitsu
    Suzuki, Seigo
    Homma, Akihiro
    Oridate, Nobuhiko
    Fukuda, Satoshi
    [J]. INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2013, 18 (05) : 824 - 828
  • [28] Integrated analysis of lncRNA-associated ceRNA network in p16-positive and p16-negative head and neck squamous cell carcinoma
    Yang, Yifan
    Feng, Ling
    Wang, Ru
    Ma, Hongzhi
    He, Shizhi
    Fang, Jugao
    [J]. MEDICINE, 2022, 101 (33) : E26120
  • [29] Pathological and Virological Studies of p16-Positive Oropharyngeal Carcinoma with a Good Response to Neoadjuvant Chemotherapy
    Inukai, Daisuke
    Kan, Taichi
    Yamanaka, Shunpei
    Okamoto, Hiroki
    Fujimoto, Yasushi
    Ito, Takanori
    Taniguchi, Natsuki
    Yamamoto, Yuuki
    Tsuzuki, Toyonori
    Takami, Akiyoshi
    Ogawa, Tetsuya
    [J]. MICROORGANISMS, 2020, 8 (10) : 1 - 9
  • [30] Intraoperative Pathology Consultation in Patients With p16-Positive Unknown Primary Squamous Cell Carcinoma
    Awad, Daniel R.
    Konanur, Anisha
    Ferris, Robert L.
    Kim, Seungwon
    Duvvuri, Umamaheswar
    Chiosea, Simion I.
    [J]. JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2024, 150 (09) : 792 - 799
12345